The stock of Avantor Inc. (NYSE:AVTR) last traded at $19.98, down -1.91% from the previous session.
Data from the available sources indicates that Avantor Inc. (NYSE:AVTR) is covered by 20 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $30.00 and a low of $20.00, we find $26.00. Given the previous closing price of $20.37, this indicates a potential upside of 27.64 percent. AVTR stock price is now -4.00% away from the 50-day moving average and -10.46% away from the 200-day moving average. The market capitalization of the company currently stands at $13.59B.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
In total, 4 analysts have assigned it a hold rating, and 12 have given it a buy rating. Brokers who have rated the stock have averaged $25.39 as their price target over the next twelve months.
With the price target of $24, Deutsche Bank recently initiated with Hold rating for Avantor Inc. (NYSE: AVTR). On October 05, 2022, Citigroup Upgraded its previous ‘Neutral’ rating to ‘Buy’ on the stock keeping its target price maintained at $28, while ‘Cowen’ rates the stock as ‘Market Perform’.
In other news, Couturier Christophe, EVP, AMEA sold 1,498 shares of the company’s stock on Apr 11. The stock was sold for $31,728 at an average price of $21.18. Upon completion of the transaction, the EVP, AMEA now directly owns 98,650 shares in the company, valued at $1.97 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 03, EVP, Biopharma Production Brophy Gerard sold 3,914 shares of the business’s stock. A total of $97,850 was realized by selling the stock at an average price of $25.00. This leaves the insider owning 108,715 shares of the company worth $2.17 million. Insiders disposed of 519,160 shares of company stock worth roughly $10.37 million over the past 1 year. A total of 0.20% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in AVTR stock. A new stake in Avantor Inc. shares was purchased by BARROW HANLEY MEWHINNEY & STRAUSS LLC during the first quarter worth $323,424,000. MERITAGE GROUP LP invested $102,746,000 in shares of AVTR during the first quarter. In the first quarter, STEADFAST CAPITAL MANAGEMENT LP acquired a new stake in Avantor Inc. valued at approximately $100,400,000. NORTH PEAK CAPITAL MANAGEMENT, LLC acquired a new stake in AVTR for approximately $88,140,000. ARTEMIS INVESTMENT MANAGEMENT LLP purchased a new stake in AVTR valued at around $83,477,000 in the second quarter. In total, there are 662 active investors with 91.70% ownership of the company’s stock.
With an opening price of $20.10 on Tuesday morning, Avantor Inc. (NYSE: AVTR) set off the trading day. During the past 12 months, Avantor Inc. has had a low of $17.91 and a high of $33.48. As of last week, the company has a debt-to-equity ratio of 1.21, a current ratio of 1.60, and a quick ratio of 1.00. According to the stock market information, the enterprise value for the company is $19.06B, which is based on a 22.25 price-to-earnings ratio, a 5.98 price-to-earnings-growth ratio, and a beta of 1.33. The fifty day moving average price for AVTR is $20.72 and a two-hundred day moving average price translates $22.27 for the stock.
The latest earnings results from Avantor Inc. (NYSE: AVTR) was released for Mar, 2023. According to the Specialty Chemicals Company, earnings per share came in at $0.29, beating analysts’ expectations of $0.28 by 0.01. This compares to $0.28 EPS in the same period last year. The net profit margin was 8.30% and return on equity was 12.90% for AVTR. The company reported revenue of $1.78 billion for the quarter, compared to $1.95 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -8.72 percent. For the current quarter, analysts expect AVTR to generate $1.8B in revenue.
Avantor Inc.(AVTR) Company Profile
Avantor, Inc. engages in the provision of mission-critical products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides logistics, chemical and equipment tracking, and glassware autoclaving, as well as scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Leave a Reply